Page 30 - Vaccine

Nearly 60 lakh vaccine doses in addition to be received by states/UTs: Govt

An additional 60 lakh Covid-19 vaccine doses will be received by the states/union territories in the next three days, the central government informed on Monday

Covid vaccine registration for 18 above from today: Things you should know

In this podcast, we are discussing the process of registration and appointment and all the other things one should keep in mind before taking the jab from and after May 1

South Korea unfreezes $30 mn Iranian funds for medicines, vaccines purchase

South Korea has released a small portion of Iranian funds in its banks for its purchase of medicine and vaccine, a senior businessman said in Tehran

Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May

The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

A new vaccine regime

Govt conducts welcome course correction

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

EAM Jaishankar rejects criticism over export of coronavirus vaccines

At an online interaction, he said India prioritised vaccination of its people while describing those as "non-serious" people who questioned why the country was exporting at all

Expanding vaccine supply

Some good moves but freer pricing needed

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Best of BS Opinion: Rise of risk capital, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The supply side

Ramping up vaccine availability has become critical

Coping with Covid

We need to stop messing around and plan ahead of the infection curve

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Best of BS Opinion: The mis-selling menace, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states